CERVical cancer: AdjuvaNt ThErapy and radical Surgery
CERVATES clinical trial
An international randomised trial of radical surgery followed by adjuvant therapy versus no further
treatment in patients with early-stage, intermediate-risk cervical cancer
Trial News
I. CERVANTES study (protocol version v2.0) was authorised through Clinical Trial Information System (CTIS) in Austria, Belgium, Italy, Poland and Spain.
Austria - 5 sites
Belgium - 6 sites
Italy - 1 site
Poland - 5 sites - First clinical site is opened for CERVANTES in Poland
Spain - 12 sites - 5 opened sites (first two Spanish patients were enroled from 2 sites)
II. 3 Brazilian Clinical Sites approved by International Review Board (IRB)
III. 60 patients enrolled from 15 recruiting centres in 10 countries - 9 more sites are waiting for their first patient
IV. Slovakia and Romania are in preparation for CTIS authorisation
Subscribe for CERVANTES Trial
newsletter*